EIF4EBP1 and acute myeloid leukemia: Therefore, this study proposed that EIF4EBP1 and EPHX1 contribute to immunodeficiency and further affect the prognostic survival status of AML patients by negatively modulating the infiltration level of CD8 T cells and γδT cells.